| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-147 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate |
2018-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-108794635-B |
| titleOfInvention |
Bovine lactoferricin-human lysozyme fusion protein, gene and application thereof |
| abstract |
The invention discloses a bovine lactoferrin peptide-human lysozyme fusion protein which is characterized in that the fusion protein is formed by sequentially connecting porcine myofibrillar protein antioxidant peptide, bovine lactoferrin peptide, chicken ovalbumin antioxidant peptide, porcine myotropomyosin antioxidant peptide, flexible connecting peptide and human lysozyme in series. Through fusion expression of the animal-derived anionic antioxidant peptide, the positive charge of the antibacterial peptide is counteracted, and the inhibition of the antibacterial peptide on host bacteria is reduced; the antioxidant peptide is beneficial to increasing the storage stability of the antibacterial peptide, and the antibacterial activity of the fusion protein to escherichia coli (ATCC 25922) is only reduced by 7.7% within 20 days after the fusion protein is placed at 4 ℃. Its viability to E.coli (ATCC 25922) was lost only 15.4% after 30 days. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114230672-A |
| priorityDate |
2018-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |